Tokyo Tape
Sign in
← Prism BioLab

Annual report

206A.TEDINET S100XCIN
Period2024-10-01 → 2025-09-30
Filed2025-12-24
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 74
MetricValuePeriodScopeSource row
Revenue¥677m2024-10-01 → 2025-09-30StandaloneNet sales
Revenue¥306m2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥113m2022-10-01 → 2023-09-30dStandaloneNet sales (5-year summary)
Revenue¥554m2021-10-01 → 2022-09-30dStandaloneNet sales (5-year summary)
Revenue¥59m2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Operating income−¥774m2024-10-01 → 2025-09-30StandaloneOperating income
Operating income−¥782m2023-10-01 → 2024-09-30StandaloneOperating income
Ordinary income−¥748m2024-10-01 → 2025-09-30StandaloneOrdinary income
Ordinary income−¥832m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥498m2022-10-01 → 2023-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥79m2021-10-01 → 2022-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥154m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥831m2024-10-01 → 2025-09-30StandaloneIncome before income taxes
Profit before tax−¥1.0bn2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Net income−¥834m2024-10-01 → 2025-09-30StandaloneProfit loss
Net income−¥1.0bn2023-10-01 → 2024-09-30StandaloneProfit loss
Net income−¥527m2022-10-01 → 2023-09-30dStandaloneNet income loss (5-year summary)
Net income¥73m2021-10-01 → 2022-09-30dStandaloneNet income loss (5-year summary)
Net income−¥156m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Total assets¥3.1bnat 2025-09-30StandaloneAssets
Total assets¥4.5bnat 2024-09-30StandaloneAssets
Total assets¥1.2bnat 2023-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.7bnat 2022-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥377mat 2025-09-30StandaloneLiabilities
Total liabilities¥1.0bnat 2024-09-30StandaloneLiabilities
Net assets / equity¥2.7bnat 2025-09-30StandaloneNet assets
Net assets / equity¥3.5bnat 2024-09-30StandaloneNet assets
Net assets / equity¥1.1bnat 2023-09-30dStandaloneNet assets
Net assets / equity¥1.7bnat 2022-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥1.1bnat 2021-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥2.9bnat 2025-09-30StandaloneCash and deposits
Cash and deposits¥4.4bnat 2024-09-30StandaloneCash and deposits
Cash & equivalents¥2.9bnat 2025-09-30StandaloneCash and cash equivalents
Cash & equivalents¥4.4bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-09-30dStandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.5bn2024-10-01 → 2025-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥150m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥514m2022-10-01 → 2023-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥103m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥69m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥244m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥40m2022-10-01 → 2023-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥34m2024-10-01 → 2025-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.4bn2023-10-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥111m2021-10-01 → 2022-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-22.822024-10-01 → 2025-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-33.532023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-19.092022-10-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥2.672021-10-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1,556.872020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥73.4at 2025-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥97.41at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥-34.5at 2023-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-15.41at 2022-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-6,231.85at 2021-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio87.6%at 2025-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.3%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.7%at 2023-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio96.2%at 2022-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE5.3%2021-10-01 → 2022-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued36,810,000at 2025-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued35,954,800at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued80,524at 2023-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued80,524at 2022-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued77,078at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees35at 2025-09-30StandaloneNumber of employees
Employees27at 2024-09-30StandaloneNumber of employees
Employees17at 2023-09-30dStandaloneNumber of employees
Employees12at 2022-09-30dStandaloneNumber of employees
Employees7at 2021-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 748
ItemContextValueUnit
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-64697000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember70000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Purchase of intangible assets inv cfPrior1YearDuration_NonConsolidatedMember-5910000JPY
Purchase of intangible assets inv cfCurrentYearDuration_NonConsolidatedMember-2986000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember17376000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Payments for lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember-49936000JPY
Payments for lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember-1328000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-244187000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-69013000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember3390902000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Payments of listing expenses fin cfPrior1YearDuration_NonConsolidatedMember-20846000JPY
Payments of listing expenses fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember32551000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember1036000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember3370055000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember33588000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-17934000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember27338000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember3258079000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-1476449000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1133943000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember4392022000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember4392022000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember2915572000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember71892000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember112692000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember－JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember2596000JPY
Compensations sgaPrior1YearDuration_NonConsolidatedMember94734000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember89122000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember571628000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember620939000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember571628000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember620939000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-12-24
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第14期(自　2024年10月１日　至　2025年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社PRISM BioLab
Company name in english cover pageFilingDateInstantPRISM BioLab Co.,LTD
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　竹原　大
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)神奈川県藤沢市村岡東二丁目26番の１
Telephone number address of registered headquarter cover pageFilingDateInstant0466-53-8383
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)管理部マネージャー　安藤　幸司

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-09-30pass
balance sheet identitynon_consolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2025-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2024-10-01/2025-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2025-09-30pass